Based on a significant number of encouraging preclinical results, ghrelin/GHS-R1A antagonism was suggested as a novel treatment approach for alcohol addiction therapy and recently, the first GHS-R1A-related compound was tested in initial human laboratory studies. The gene discussed is GHRL; the disease is Addictive alcohol use.